Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Cardiac Disease Specialists
mi
from
Atlanta, GA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Cardiac Disease Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Massachusetts General Hospital
mi
from
Boston, MA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
VA Boston Healthcare System
mi
from
West Roxbury, MA
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
VA Boston Healthcare System
mi
from
West Roxbury, MA
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Michigan Heart, PC
mi
from
Ypsilanti, MI
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Michigan Heart, PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Mid America Heart Institute-Saint Luke's Hospital
mi
from
Kansas City, MO
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Mid America Heart Institute-Saint Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
St. Michael's Medical Center
mi
from
Newark, NJ
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
St. Michael's Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Good Samaritan Hospital
mi
from
Dayton, OH
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Heart Institute of the Cascades
mi
from
Bend, OR
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Heart Institute of the Cascades
mi
from
Bend, OR
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Rhode Island Hospital
mi
from
Providence, RI
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated:  12/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients
Status: Enrolling
Updated: 12/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins
Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins The RELIEVE Study
Status: Enrolling
Updated:  12/8/2015
Lake Washington Vascular Surgery
mi
from
Bellevue, WA
Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins
Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins The RELIEVE Study
Status: Enrolling
Updated: 12/8/2015
Lake Washington Vascular Surgery
mi
from
Bellevue, WA
Click here to add this to my saved trials
Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
Adjunct Vitamin D Therapy as a Means to Reduce the Disparity in Subclinical Target Organ Cardiac Damage Among Vulnerable Hypertensive Patients
Status: Enrolling
Updated:  12/8/2015
Detroit Receiving Hospital
mi
from
Detroit, MI
Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
Adjunct Vitamin D Therapy as a Means to Reduce the Disparity in Subclinical Target Organ Cardiac Damage Among Vulnerable Hypertensive Patients
Status: Enrolling
Updated: 12/8/2015
Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Arizona Pediatric Cardiology Consultants
mi
from
Phoenix, AZ
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Arizona Pediatric Cardiology Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Indiana University
mi
from
Indianapolis, IN
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
University of Michigan
mi
from
Ann Arbor, MI
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Washington University
mi
from
St. Louis, MO
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Cardiothoracic and Vascular Surgeons and Austin Heart
mi
from
Austin, TX
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Cardiothoracic and Vascular Surgeons and Austin Heart
mi
from
Austin, TX
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Methodist Healthcare System of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated:  12/8/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Status: Enrolling
Updated: 12/8/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Prediction of ARrhythmic Events With Positron Emission Tomography
Hibernating Myocardium and Sudden Cardiac Death
Status: Enrolling
Updated:  12/8/2015
SUNYBuffalo
mi
from
Buffalo, NY
Prediction of ARrhythmic Events With Positron Emission Tomography
Hibernating Myocardium and Sudden Cardiac Death
Status: Enrolling
Updated: 12/8/2015
SUNYBuffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
mi
from
Boston, MA
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
mi
from
Boston, MA
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
New York University
mi
from
New York, NY
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Vanderbilt University
mi
from
Nashville, TN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
The Mayo Clinic
mi
from
Rochester, MN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Management of New-Onset Postoperative Atrial Fibrillation
Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF
Status: Enrolling
Updated:  12/10/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Management of New-Onset Postoperative Atrial Fibrillation
Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF
Status: Enrolling
Updated: 12/10/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Acute Decompensated Heart Failure-Pilot Study
Status: Enrolling
Updated:  12/10/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Acute Decompensated Heart Failure-Pilot Study
Status: Enrolling
Updated: 12/10/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Retrospective Review of Management of Infective Endocarditis
A Retrospective Review of the Management of Infective Endocarditis in Patients at Virginia Commonwealth University Medical Center From 1996-2006
Status: Enrolling
Updated:  12/10/2015
Virginia Commonweath University MCV Hospital
mi
from
Richmond, VA
Retrospective Review of Management of Infective Endocarditis
A Retrospective Review of the Management of Infective Endocarditis in Patients at Virginia Commonwealth University Medical Center From 1996-2006
Status: Enrolling
Updated: 12/10/2015
Virginia Commonweath University MCV Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Huntsville, AL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Mobile, AL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Ft. Smith, AR
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Ft. Smith, AR
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Chula Vista, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Mission Viego, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Mission Viego, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Monterey Park, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Monterey Park, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Oceanside, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Redondo Beach, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
San Diego, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Sylmar, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Torrance, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Yuba City, CA
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Yuba City, CA
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Hartford, CT
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Sarasota, FL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Tampa, FL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
mi
from
Lombard, IL
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
mi
from
Lombard, IL
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated:  12/10/2015
Clinical Research Facility
mi
from
Muncie, IN
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 12/10/2015
Clinical Research Facility
mi
from
Muncie, IN
Click here to add this to my saved trials